Literature DB >> 10576067

What role for statins? A review and economic model.

S Ebrahim1, G Davey Smith, C McCabe, N Payne, M Pickin, T A Sheldon, F Lampe, F Sampson, S Ward, G Wannamethee.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10576067

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN： 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  12 in total

1.  National smoking cessation services at risk.

Authors:  M Raw; A McNeill; J Watt; D Raw
Journal:  BMJ       Date:  2001-11-17

2.  Treating the patient or the population? Part 2. Judging the benefit of a treatment to society as a whole.

Authors:  T D Heller; R F Heller; S Pattison; R Fletcher
Journal:  West J Med       Date:  2001-08

3.  Secondary prevention of cardiovascular disease: a randomised trial of training in information management, evidence-based medicine, both or neither: the PIER trial.

Authors:  Julia Langham; Helen Tucker; David Sloan; Jane Pettifer; Simon Thom; Harry Hemingway
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

Review 4.  A review of health care models for coronary heart disease interventions.

Authors:  K Cooper; S C Brailsford; R Davies; J Raftery
Journal:  Health Care Manag Sci       Date:  2006-11

5.  Prevention of coronary heart disease through treatment of infection with Chlamydia pneumoniae? Estimation of possible effectiveness and costs.

Authors:  C Sanderson; M Kubin
Journal:  Health Care Manag Sci       Date:  2001-12

Review 6.  Statins for the primary prevention of cardiovascular disease.

Authors:  Fiona Taylor; Kirsten Ward; Theresa Hm Moore; Margaret Burke; George Davey Smith; Juan-Pablo Casas; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

7.  A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United Kingdom.

Authors:  Nigel Buller; David Gillen; Roman Casciano; John Doyle; Koo Wilson
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

8.  The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial.

Authors:  Cheryl L L Carling; Doris Tove Kristoffersen; Victor M Montori; Jeph Herrin; Holger J Schünemann; Shaun Treweek; Elie A Akl; Andrew D Oxman
Journal:  PLoS Med       Date:  2009-08-25       Impact factor: 11.069

Review 9.  Statins for the primary prevention of cardiovascular disease.

Authors:  Fiona Taylor; Mark D Huffman; Ana Filipa Macedo; Theresa H M Moore; Margaret Burke; George Davey Smith; Kirsten Ward; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

10.  Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study.

Authors:  D A Lawlor; C Bedford; M Taylor; S Ebrahim
Journal:  J Epidemiol Community Health       Date:  2003-02       Impact factor: 3.710
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.